Dermata Therapeutics, Inc. - SIC # 2840 -

Ticker Exchange SIC # Website Latest Ticker
DRMA Nasdaq 2840 www.dermatarx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Dermata Therapeutics, Inc.

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026 - May 13th, 2026 2:05 pm
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System - Apr 2nd, 2026 6:30 am
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 - Mar 26th, 2026 3:15 pm
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing - Mar 10th, 2026 6:30 am
Dermata Opens a New Chapter with the Release of Tome Skincare - Mar 5th, 2026 7:00 am
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office - Jan 20th, 2026 6:05 am
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Dec 29th, 2025 2:05 pm
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Dec 24th, 2025 6:00 am
A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity - Dec 4th, 2025 6:00 am
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results - Nov 14th, 2025 2:05 pm
Dermata Announces Acceptance of Patent Application for Next-Generation Acne Treatment by Australian Patent Office - Oct 2nd, 2025 6:00 am
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing - Sep 18th, 2025 6:35 am
Dermata Therapeutics Announces Presentation of Abstract at the European Academy of Dermatology and Venereology Congress 2025 - Sep 16th, 2025 11:00 pm
Life Science Virtual Investor Forum Agenda Announced for September 18th - Sep 16th, 2025 9:57 am
Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th - Sep 16th, 2025 6:35 am
Dermata Therapeutics Announces Strategic Pivot to Over-the-Counter Skin Care Treatments - Sep 10th, 2025 6:00 am
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - Aug 13th, 2025 3:00 pm